Cellen Therapeutics 🇬🇧
“Bridging the gap between cannabis research and NHS patients.”
Cellen Therapeutics is a UK-based medical cannabis company founded in 2019, focusing on the development and distribution of standardised cannabis-based medicines for NHS and private patients across the United Kingdom.
About Cellen Therapeutics
Cellen Therapeutics was founded in 2019 in the United Kingdom with a focus on making high-quality medical cannabis medicines available to patients through both NHS and private channels. The company operates as a licensed importer and distributor, working with EU-GMP certified manufacturers internationally.
Cellen's portfolio includes a range of flower, oil and specialised cannabis preparations, all selected for consistent cannabinoid profiles and clinical applicability. The company undertakes rigorous quality assurance, including independent batch release testing for all products entering the UK market.
Cellen Therapeutics is actively engaged in clinical research and works collaboratively with NHS trusts and specialist clinicians to build the evidence base for medical cannabis in the UK. Their ambition is to see cannabis medicines integrated into mainstream NHS treatment pathways.
Certifications & Standards
Home Office Licensed, MHRA Compliant, EU-GMP Supply Chain
How to Get a Medical Cannabis Prescription
Entirely online — no GP referral needed. Most patients prescribed within 5–10 days.
Medical cannabis is a Schedule 2 controlled drug available on private prescription from GMC-registered specialists.
Full Beginner Guide →